Joel Greenblatt - Gotham Asset Management
Holding/activity history for Viking Therapeutics, Inc. (VKTX)
← All VKTX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 260,778 | 0.03 | Add 9.01% | <0.01 | $25.77–37.50 · VW $32.08i | $8,485,716 | SEC |
| 2025 Q4 | 239,229 | 0.03 | Add 40.99% | <0.01 | $26.17–43.15 · VW $35.92i | $8,416,076 | SEC |
| 2025 Q3 | 169,683 | 0.02 | Buy | 0.02 | $22.96–42.23 · VW $29.53i | $4,459,269 | SEC |
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $18.92–30.28 · VW $26.60i | SEC | |
| 2025 Q1 | 24,500 | <0.01 | Buy | <0.01 | $23.27–43.55 · VW $30.66i | $591,675 | SEC |
Price snapshot:
Current price$38.12
Avg. buy price$29.17
+/- since buy30.68%
52-week low$22.96
52-week high$43.15